Standout Papers

Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD 2022 2026 2023 2024135
  1. Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD (2022)
    Mary P. Moore, Rory P. Cunningham et al. Hepatology

Immediate Impact

60 standout
Sub-graph 1 of 21

Citing Papers

Unraveling the AMPK-SIRT1-FOXO Pathway: The In-Depth Analysis and Breakthrough Prospects of Oxidative Stress-Induced Diseases
2025 Standout
The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation
2025 Standout
2 intermediate papers

Works of Mary P. Moore being referenced

Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH
2021
A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD
2020

Author Peers

Author Last Decade Papers Cites
Mary P. Moore 241 129 121 13 321
Silvia Sabatini 240 133 72 18 364
Cristina Rodríguez‐Juan 229 73 94 11 347
Christina‐Maria Flessa 185 68 72 11 287
Linda Frost 263 116 65 11 353
Roxana Gutiérrez‐Vidal 170 76 86 13 358
Nynke Simons 270 213 78 16 346
Rama Ganga 155 87 58 16 281
Sulin Zheng 134 96 66 13 347
Lampros Chrysavgis 239 102 88 17 363
Christiane Villescaz 200 183 59 7 332

All Works

Loading papers...

Rankless by CCL
2026